Drugs Made In America Acquisition II 10-K: Net income $4.19M, Net loss $0.15M

About this update from Drugs Made In America Acquisition Ii Corp.

Drugs Made In America Acquisition II reported a net income of $4,187,050 for the period driven primarily by $4,933,800 of interest income on its trust account, while recording a net loss of $151,719 for the interim period Aug 23, 2024–Dec 31, 2024 reflecting general and administrative expenses. The company has no operating revenues as it remains in a pre-combination stage and continues to incur public-company costs. Activities during the period focused on completing the IPO, maintaining the trust, and preparing for an initial business combination in the pharmaceutical sector.Financial HighlightsNet Income: $4,187,050, primarily from $4,933,800 interest income on the trust account.Net Loss (Aug 23, 2024–Dec 31, 2024): $151,719, comprised of general and administrative costs.Revenue / Sales: Omitted from Part II Item 7/Item 8; not presented.Gross Profit: Omitted from Part II Item 7/Item 8; not presented.Net Income Per Share: Omitted from Part II Item 7/Item 8; not presented.Business HighlightsIPO & Trust Funding: Completed a $500 million initial public offering and placed the proceeds in a trust to fund an initial business combination focused on pharmaceuticals.Stage of Operations: Early-stage blank-check company with no operating revenue; primary activities are searching for and performing due diligence on potential targets.Financing & Runway: Incurs ongoing public-company administrative and listing costs; secured bridge convertible notes and an LOI for up to $1.4 million to cover transaction and audit expenses.Sponsor & Governance: Sponsor acknowledged a limited role and agreed to cooperate on sponsor share transfers; an administrative services arrangement was cancelled.Outlook: Continued focus on identifying and completing an initial business combination in the pharmaceutical space, with financing arrangements in place to support transaction-related costs.Original SEC Filing: This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

View stock analysis, news, and events for Drugs Made In America Acquisition Ii Corp.